No influence of amyloid-β-degrading neprilysin activity on prion pathogenesis

Journal of General Virology

Volumn 86, Issue 6, 2005, Pages 1861-1867

  Glatzel, Markus ^a   Mohajeri, M Hasan ^b   Poirier, Raphael ^b   Nitsch, Roger M ^b   Schwarz, Petra ^a   Lu, Bao ^c   Aguzzi, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE; PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN INFECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE DOSAGE; GENE OVEREXPRESSION; IN VIVO STUDY; INCUBATION TIME; MOUSE; NEUROMODULATION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS;

AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; BREEDING; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; NEPRILYSIN; PRION DISEASES; PRPC PROTEINS; PRPSC PROTEINS; SUBSTRATE SPECIFICITY;

EID: 20044371003     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80811-0     Document Type: Article

References (24)

1. Aguzzi, A. & Haass, C. (2003). Games played by rogue proteins in prion disorders and Alzheimer's disease. Science 302, 814-818.
2. Aguzzi, A. & Polymenidou, M. (2004). Mammalian prion biology: one century of evolving concepts. Cell 116, 313-327.
3. Backstrom, J. R., Lim, G. P., Cullen, M. J. & Tökés, Z. A. (1996). Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40). J Neurosci 16, 7910-7919.
4. Borchelt, D. R., Davis, J., Fischer, M. & 8 other authors (1996). A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13, 159-163.
5. Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M. & Weissmann, C. (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582.
6. Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M. & Weissmann, C. (1993). Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347.
7. Checler, F. & Vincent B. (2002). Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci 25, 616-620.
8. Chen, S. G., Teplow, D. B., Parchi, P., Teller, J. K., Gambetti, P. Autilio-Gambetti, L. (1995). Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270, 19173-19180.
9. Enari, M., Flechsig, E. & Weissmann, C. (2001). Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A 98, 9295-9299.
10. Fischer, M., Rülicke, T., Raeber, A., Sailer, A, Moser, M., Oesch, B., Brandner, S., Aguzzi, A. & Weissmann, C. (1996). Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15, 1255-1264.
11. C expression in the peripheral nervous system is a determinant of prion neuroinvasion. J Gen Virol 81, 2813-2821.
12. Glatzel, M., Heppner, F. L., Albers, K. M. & Aguzzi, A. (2001). Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31, 25-34.
13. Glatzel, M., Abela, E., Maissen, M. & Aguzzi, A. (2003). Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349, 1812-1820.
14. Iwata, N., Tsubuki, S., Takaki, Y. & 7 other authors (2001). Metabolic regulation of brain Aβ by neprilysin. Science 292, 1550-1552.
15. Jiménez-Huete, A., Lievens, P. M. J., Vidal, R., Piccardo, P., Ghetti, B., Tagliavini, F., Frangione, B. & Prelli, F. (1998). Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 153, 1561-1572.
16. Klöhn, P.-C., Stoltze, L., Flechsig, E., Enari, M. & Weissmann, C. (2003). A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci U S A 100, 11666-11671.
17. Lu, B., Gerard, N. P., Kolakowski, L. F., Jr, Bozza, M., Zurakowski, D., Finco, O., Carroll, M. C. & Gerard, C. (1995). Neutral endopeptidase modulation of septic shock. J Exp Med 181, 2271-2275.
18. + dendritic cells and GT1-1 neuronal cells. J Virol 78, 4776-4782.
19. Mohajeri, M. H., Kuehnle, K., Li, H., Poirier, R., Tracy, J. & Nitsch, R. M. (2004). Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease. FEBS Lett 562, 16-21.
20. Prusiner, S. B., Cochran, S. P., Groth, D. F., Downey, D. E., Bowman, K. A. & Martinez, H. M. (1982). Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11, 353-358.
21. Shirotani, K., Tsubuki, S., Iwata, N. & 9 other authors (2001). Neprilysin degrades both amyloid β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem 276, 21895-21901.
22. Taraboulos, A., Jendroska, K., Serban, D., Yang, S.-L., DeArmond, S. J. & Prusiner, S. B. (1992). Regional mapping of prion proteins in brain. Proc Natl Acad Sci U S A 89, 7620-7624.
23. Turner, A. J. (2003). Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries. Biochem Soc Trans 31, 723-727.
24. Vincent, B., Paitel, E., Saftig, P., Frobert, Y., Hartmann, D., De Strooper, B., Grassi, J., Lopez-Perez, E. & Checler, F. (2001). The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 276, 37743-37746.